Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RDGL Vivos Inc (QB)

-0.00216 (-4.03%)
Nov 30 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 207,418
Bid Price 0.0498
Ask Price 0.055
News -
Day High 0.054


52 Week Range


Day Low 0.05
Company Name Stock Ticker Symbol Market Type
Vivos Inc (QB) RDGL OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.00216 -4.03% 0.05144 16:00:05
Open Price Low Price High Price Close Price Prev Close
0.054 0.05 0.054 0.05144 0.0536
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
19 207,418 $ 0.052669 $ 10,924 - 0.04119 - 0.1195
Last Trade Time Type Quantity Stock Price Currency
15:25:22 777 $ 0.05144 USD

Vivos Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 19.00M 369.38M 295.92M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vivos (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No RDGL Message Board. Create One! See More Posts on RDGL Message Board See More Message Board Posts

Historical RDGL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0510.0540.04630.0525782545,2600.000440.86%
1 Month0.05750.05890.041190.0520118433,495-0.00606-10.54%
3 Months0.05980.0750.041190.058211366,189-0.00836-13.98%
6 Months0.05740.080.041190.0571646339,648-0.00596-10.38%
1 Year0.050750.11950.041190.0630474451,0810.000691.36%
3 Years0.0240.310.0240.09948311,213,1180.02744114.33%
5 Years0.01350.310.00240.05206821,570,3280.03794281.04%

Vivos (QB) Description

Vivos Inc, developed an yttrium-90 brachytherapy device to combat cancer in humans and animals. Testing at Washington State University, the University of Missouri and our pilot veterinary clinic has verified the safety to the patient, the therapist and the family members. IsoPet is commercially available for animal therapy and can deliver very high doses to solid tumors with a single same day therapy. Pre-clinical testing is in progress to generate key data for an Investigational Devise Exemption to the FDA to begin human clinical trials.

Your Recent History

Delayed Upgrade Clock